Jennifer Todesca

Jennifer Todesca is currently the Operations Manager at Expansion Therapeutics. Jennifer has over 18 years of experience in the scientific field, with a focus on Gauchers and Parkinson's Disease research. Jennifer has worked as a Scientist at Lysosomal Therapeutics, an Associate Scientist III at Link Medicine, and a Research Associate at Pfizer. Jennifer has also served as a Laboratory Manager at Harvard Medical School. Throughout their career, Jennifer has been responsible for culturing, testing and growing human fibroblasts, training Phlebotomists, developing experimental protocols, treating cells and harvesting samples for ongoing in-vivo research projects. Jennifer has also maintained and banked all cell lines (Fibroblast, Rat Primary Astrocyte), performed phlebotomy draws when needed, isolated and treated human peripheral blood mononuclear cells (PBMCs), homogenized and processed human, monkey, and mouse brain samples, and run molecular screening studies.

Jennifer Todesca has a certification from Harvard University in Contract Law and a certification from the Commonwealth of Massachusetts in Notary Public.

Jennifer Todesca reports to Renato Skerlj, CEO, President & Board Member. Some of their coworkers include Andrew Good - VP, Computational Chemistry, Tiviane Vu - Project Manager, and Mark Ledeboer - Senior Vice President, Drug Discovery.